Implementation of a Multi-Modal Brain Stimulation Approach in Early Stage Clinical Trials
Time: 12:00 pm
day: Day Two
• Transcranial Magnetic Stimulation (TMS) electrodiagnostic markers in Phase 1a studies to investigate pharmacodynamic profiles of novel drugs;
• Development of TMS electrodiagnostic markers as a tool to assess human brain excitability in neurological conditions
• Can we develop TMS-electrodiagnostic markers as a test to track disease progression and to evaluate the beneficial effects of pharmacological treatments?